David Adelson MD
Christine Ahn MD
Sanah Ali MD
Carl Allen DDS, MSD
Brandon Ayres MD
Howard P. Baden MD
Yevgeniy Balagula MD
Robert Baran MD
Keira Barr MD
Sid Barsky MD
Gregory J. Basura MD, Ph.D
Donald Belsito MD
Jeffrey D. Bernhard MD
Jesse Berry MD
Victor Blanco MD
Benjamin R. Bohaty MD
William Bonnez MD
Mina Botros MD
Jeremy S. Boyd MD
Sarah Brenner MD
Robert A. Briggaman MD
Robert Brodell MD
Roman Bronfenbrener MD
Walter Brooks MD
Daniel Bryan MD
William Buckley MD
Philip Bulterys MD, PhD
Susan Burgin MD
Sonya Burton MD
Sean P. Bush MD, FACEP
Jeffrey Callen MD
Scott Camazine MD
Michael Cardwell
Shelley D. Cathcart MD
Robert Chalmers MD, MRCP, FRCP
Chia-Yu Chu MD, PhD
Flavio Ciferri MD
Maria Rosa Cordisco MD
Noah Craft MD, PhD
John T. Crissey MD
Harold E. Cross MD, PhD
Charles E. Crutchfield III MD
Adriana Cruz MD
Donna Culton MD, PhD
Bart J. Currie MBBS, FRACP, DTM&H
Chicky Dadlani MD
Alexander Dane DO
Roxana Daneshjou MD
C. Ralph Daniel III MD
Thomas Darling MD, PhD
Steven Daveluy MD
William Delaney MD
Shreya Deoghare MD
Alex Derstenfeld
Damian P. DiCostanzo MD
Benedict F. DiGiovanni MD
Ncoza Dlova MD
Erin Doudt
James Earls MD
Libby Edwards MD
Melissa K. Egge MD
Charles N. Ellis MD
Rachel Ellis MD
David Elpern MD
Nancy Esterly MD
Stephen Estes MD
E. Dale Everett MD
Janet Fairley MD
David Feingold MD
Jennifer J. Findeis-Hosey MD
Benjamin Fisher MD
Robert Warne Fitch, MD
Henry Foong MBBS, FRCP
David Foster MD, MPH
Lindy P. Fox MD
Brian D. Foy PhD
Michael Franzblau MD
Vincent Fulginiti MD
Sunir J. Garg MD, FACS
Kevin J. Geary MD
Sharon Glick MD
Lowell Goldsmith MD, MPH
Sethuraman Gomathy MD
Bernardo Gontijo MD, PhD
Ayman Grada MD
Kenneth Greer MD
Kenneth G. Gross MD
Alan Gruber MD
Nathan D. Gundacker MD
Akshya Gupta MD
Vidal Haddad MSC, PhD, MD
Edward Halperin MD, MA
Ronald Hansen MD
John Harvey
Rizwan Hassan MD
Michael Hawke MD
Jason E. Hawkes MD
Peter W. Heald MD
Martha Hickman MD
David G. Hicks MD
Sarah Hocker DO
Ryan J. Hoefen MD, PhD
Li-Yang Hsu MD
Jennifer Huang MD
William W. Huang MD, MPH, FAAD
Eric F. Ingerowski MD
Sanjana Iyengar MD
Alvin H. Jacobs MD
Randy Jacobs MD, FAAD
Saagar Jadeja MD
Shahbaz A. Janjua MD
Joshua J. Jarvis MD
Noman Javed, MD
Beverly A. Johnson MD
Kit Johnson
Zachary John Jones MD
Harsimran Kaur MD
Robert Kalb MD
Katherine Kaproth-Joslin MD, PhD
Philip J. Katzman MD
A. Paul Kelly MD
Henry Kempe MD
Loren Ketai MD
Sidney Klaus MD
Sasank Konda, MD, FAAD
Ashwin Kosambia MD
Jessica A. Kozel MD
Carl Krucke
Mario E. Lacouture MD
Joseph Lam MD
Alfred T. Lane MD
Gerald S. Lazarus MD
Edith Lederman MD
Nahyoung Grace Lee MD
Ronald J. Lee MD
Pedro Legua MD, PhD
Robert Levin MD
Bethany Lewis MD
Sue Lewis-Jones FRCP, FRCPCH
Taisheng Li MD
Christine Liang MD
Shari Lipner MD, PhD
Adam Lipworth MD
Jenna Lullo MD
Jason Maguire MD
Mark Malek MD, MPH
Jere Mammino DO
Ricardo Mandojana MD
Lynne Margesson MD
Thomas J. Marrie MD
Maydel Martinez MD
Ralph Massey MD
Patrick McCleskey MD
Lynn McKinley-Grant MD
Karen McKoy MD
Thomas McMeekin MD
Josette McMichael MD
Somchai Meesiri MD
Joseph F. Merola MD
Mary Gail Mercurio MD
Anis Miladi MD
Larry E. Millikan MD
Dan Milner Jr. MD
Zaw Min MD
Nequesha Mohamed MD
Stephanie Montero
Alastair Moore MD
Martha Alejandra Morales-Sánchez MD
Keith Morley MD
Dean Morrell MD
Samuel Moschella MD
Surya N. Mundluru MD
Nicholas Erick Nacca MD
Rehan Naseemuddin MD
Taimor Nawaz MD
Vic Newcomer MD
John Nguyen MD
Matilda Nicholas MD, PhD
Thomas P. Nigra MD
Dylan Norton MD
Steven Oberlender MD, PhD
Maria Teresa Ochoa MD
Edward O'Keefe ND
Daniel C. Oppenheimer MD
Art Papier MD
Lawrence Parish MD
Tanner Parrent MD
Mukesh Patel MD
Lauren Patty-Daskivich MD
David Peng MD, MPH
Robert Penne MD
Nitipong Permpalung MD
Frank Johannes Plate MD, PhD
Miriam Pomeranz MD
Doug Powell MD
Harold S. Rabinovitz MD
Christopher J. Rapuano MD
Sireesha Reddy MD
Angela Restrepo MD, PhD
Cynthia Reyes-Barron MD
Bertrand Richert MD, PhD
J. Martin Rodriguez, MD, FACP
Theodore Rosen MD
Misha Rosenbach MD
Courtney Schadt MD
Scott Schiffman MD
Robert H. Schosser MD
Glynis A. Scott MD
Carlos Seas MD, MSc
Deniz Seçkin MD
Daniel Sexton MD
Paul K. Shitabata MD
Tor Shwayder MD, FAAP, FAAD
Daniel Siegel, MD
Elaine Siegfried MD
Gene Sienkiewicz MD
Christye Sisson
Jonathan Soh MD
Philip I. Song MD
Mary J. Spencer MD, FAAP
Lawrence B. Stack MD
Sarah Stein MD
William Van Stoecker MD
Frances J. Storrs MD
Erik J. Stratman MD
Lindsay C. Strowd MD
Erika Summers MD
Belinda Tan MD, PhD
Robert Tomsick MD
Hensin Tsao MD, PhD
Richard P. Usatine MD
Jenny Valverde MD
Vishalakshi Viswanath MD
Susan Voci MD
Lisa Wallin ANP, FCCWS
Douglas Walsh MD
Ryan R. Walsh MD
George Watt MD
Erin X. Wei MD
Zachary Werle DO
Clayton E. Wheeler MD
Sally-Ann Whelan MS, NP, CWOCN
Danielle Wilbur MD
Jan Willems MD, PhD
Victoria L. Williams MD
James Henry Willig MD, MPH
Kelly Wilmas MD
Karen Wiss MD
Vivian Wong MD, PhD
Sook-Bin Woo MS, DMD, MMSc
Jamie Woodcock MD
Stephen J. Xenias MD
Nathaniel Yohannes
Lisa Zaba MD
Vijay Zawar MD
Bonnnie Zhang MD
Carolyn Ziemer MD
Barret Zimmerman MD
Jeffrey P. Zwerner MD, PhD
Organizations
American Academy of Dermatology
Am. Journal of Trop. Med & Hygiene
Armed Forces Pest Management Board
Blackwell Publishing
Broward Health Medical Center
Bugwood Network
Centers For Disease Control and Prevention
Centro Internacional de Entrenamiento e Investigaciones Mèdicas (CIDEIM)
Dermatology Associates of Concord
Dermatology Online Journal
East Carolina University (ECU), Division of Dermatology
International Atomic Energy Agency
Massachusetts Medical Society
NYU Department of Dermatology
Oregon Health & Science University (OHSU)
Oxford University Press
Radiological Society of North America
Washington Hospital Center
Wikipedia
World Health Organization
Human herpesvirus 8 (HHV-8) belongs to the family of human gamma-2 herpesviruses. Overall seroprevalence in the United States is 1%-5%. It is higher among men who have sex with men (MSM) (20%-77%), regardless of HIV infection status; it is also higher in some Mediterranean (10%-20%) and sub-Saharan African (30%-80%) countries. HHV-8 is formerly known as Kaposi sarcoma-associated herpesvirus (KSHV) and is associated with all forms of Kaposi sarcoma (including AIDS-associated and non-AIDS-associated Kaposi sarcoma). HHV-8 is also associated with primary effusion lymphoma and multicentric Castleman disease. These, in addition to Kaposi sarcoma, will be discussed here. Other diseases linked to HHV-8 infection are Kaposi sarcoma-associated herpesvirus inflammatory cytokine syndrome, multiple myeloma, angiosarcoma, pemphigus vulgaris, primary pulmonary hypertension, and sarcoidosis.
HHV-8 infection in immunocompetent children as well as organ transplant recipients may be associated with a primary infection syndrome, which is characterized by fever, rash, lymphadenopathy, bone marrow failure, and sometimes rapid progression to Kaposi sarcoma. Most cases of chronic infection, however, are asymptomatic.
Kaposi Sarcoma Kaposi sarcoma (KS) is the first malignancy where HHV-8 was implicated as the causal agent of disease. With the onset of the HIV epidemic, its incidence has dramatically increased and received more attention.
There are 4 types of KS:
Classic KS – First described by Hungarian dermatologist Moritz Kaposi in 1872. Mainly affects the lower extremities of elderly Mediterranean and Ashkenazi Jewish men. Cutaneous lesions of classic KS are not aggressive and are not associated with HIV infection.
Endemic KS – Endemic in parts of sub-Saharan Africa, it affects both children and adults. Not known to be related to HIV infection. Presents as cutaneous lesions, such as with classic KS, but they tend to be aggressive and disseminate to lymph nodes and bone.
Organ transplant-associated KS – Associated with solid organ transplantation and immunosuppression. Can be due to either donor-derived infection or reactivation of latent HHV-8 in the recipient. Clinical manifestations are similar to AIDS-associated KS. Lesions usually resolve on judicious decreasing of immunosuppression.
Epidemic, or AIDS-associated KS – Low-grade tumor that originates from vascular endothelial cells. HIV-positive MSM are at the highest risk (by 20-fold) for developing KS compared with other HIV-infected persons. Regarded as an AIDS-defining illness and the most common tumor in patients with advanced AIDS. The risk of KS is >20 000 times higher in persons with AIDS than in the general population, and the risk is >300 times higher in AIDS patients than in other immunocompromised persons. Those with CD4 counts <200 cells/mm3 are known to have the highest risk of developing KS. The incidence of KS has been significantly decreased with the introduction of active antiretroviral therapy (ART), although initiation of ART or steroids has been associated with exacerbation of pre-existing KS.
The clinical manifestations of AIDS-associated KS include cutaneous KS and visceral KS. Cutaneous KS is by far the most common clinical presentation and mostly involves the lower extremities, face, oral mucosa, and genitalia. Lesions are characteristically painless, nonpruritic violaceous to reddish macules, plaques, or nodules. The lesions can change to a brown color due to hemosiderin deposition. Rarely, the lesions may be fungating. Swelling of the face, lower extremities, and genitalia is sometimes evident secondary to the lymphedema from lymphadenopathy and cytokine release from KS lesions.
Visceral KS can affect any organ, but most notably affects the oral cavity, gastrointestinal tract (GI), and respiratory system. It is typically a late manifestation of the disease.
Oral mucosa – The palate and the gingiva are most commonly affected. Often, a dentist is the first to identify the lesions. Lesions are prone to injury during chewing, which results in pain, bleeding, or ulceration.
GI – Can be asymptomatic or may cause abdominal pain, nausea, vomiting, or rarely bloody diarrhea.
Pulmonary – Can present with chest pain, shortness of breath, hemoptysis, or an incidental finding on chest X-ray.
Primary Effusion Lymphoma Primary effusion lymphoma (PEL) is a subtype of non-Hodgkin B-cell lymphoma typically associated with HHV-8 infection in immunocompromised individuals. It was described in 1984 in HIV-infected patients. PEL is an uncommon tumor among patients with HIV, accounting for 3% of HIV-associated lymphomas. PEL has rarely been reported in non-HIV patients, solid organ transplant recipients, and patients with chronic hepatitis C infection. It has a strong male predominance and primarily affects HIV patients with low CD4 counts.
PEL involves serosal surfaces of the body cavities, which include the pleura (60%-90%), pericardium (30%), peritoneum (30%-60%), and joint spaces. Thus it is also known as body cavity lymphoma. Clinical manifestations depend on the extent of serous effusions within those closed serosal surfaces, but there is no lymphomatous mass formation within those cavities. Patients usually present with dyspnea, chest pressure (secondary to pleural or pericardial effusion), abdominal distension and discomfort (due to ascites), or joint swelling.
Multicentric Castleman Disease Castleman disease was first described by American pathologist Benjamin Castleman in 1956 as a localized disease characterized by a solitary mediastinal lymph node enlargement, which is now called unicentric Castleman disease (UCD). It usually affects young adults. Typically asymptomatic, it is commonly discovered as an incidental finding on imaging studies. After complete resection of the involved lymph node, most patients have a favorable prognosis.
In contrast, multicentric Castleman disease (MCD) is characterized by generalized peripheral lymphadenopathy, hepatomegaly, fevers, and night sweats. Unlike UCD, it is strongly associated with HIV and HHV-8 infections. Unlike KS, the incidence of MCD increased after the introduction of ART; the reason for this discrepancy is unknown.
MCD has a male preponderance, and most patients are between 50 and 65 years old, although HIV-infected patients are typically younger. HIV-infected patients with MCD are almost always infected with HHV-8. In non-HIV patients with MCD, HHV-8 is responsible for 50% of cases. Known risk factors for MCD are older primary age, non-white, higher CD4 count (more than >200 cells/mm3), and ART-naïve. MCD in HIV-infected patients tends to be aggressive, and these patients are commonly acutely ill within 3 months from the time of diagnosis. Interleukin 6 (IL-6) is expressed at high levels in the germinal centers of the affected lymph nodes and plays a role in lytic replication of HHV-8 virus in patients with MCD. For this reason, anti-IL-6 therapy is regarded as a therapeutic option in a particular subset of patients.
Clinical manifestations of MCD are fever, night sweats, weight loss, peripheral lymphadenopathy, and hepatosplenomegaly. Other less common presentations include skin rash, perioral pemphigus, edema, and ascites. MCD can be associated with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes), autoimmune hemolytic anemia, immune thrombocytopenia, and acquired factor VIII deficiency. Interestingly, KS can coexist with MCD in the same patient.
Codes
ICD10CM: B10.89 – Other human herpesvirus infection
SNOMEDCT: 427605002 – Human Herpesvirus 8
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
KS Bacillary angiomatosis is the most important differential diagnosis for cutaneous lesions of AIDS-associated KS because of the resemblance of skin lesions. It is caused by Bartonella henselae and Bartonella quintana, which are fastidious gram-negative bacilli. Identification of Bartonella species with Warthin-Starry silver staining on culture helps to aid diagnosis of bacillary angiomatosis. However, KS and bacillary angiomatosis both could be present simultaneously in the same patient.
PEL A broad differential diagnosis includes other systemic lymphomas with secondary involvement of the serosal surfaces (such as extranodal Burkitt lymphoma). Positivity of HHV-8 virus in the malignant cells distinguishes PEL from other types of lymphoma.
Single axial CT image demonstrates a soft tissue nodule in the right anterior chest, consistent with metastatic disease in this patient with Kaposi Sarcoma.